teva pharmaceuticals introduces the first generic glp-1 for weight loss Liraglutide (Victoza) Becomes Generic Receptor Agonist Weight-loss GLP-1 pill approved for

Importantly, all-cause mortality was significantly reduced in patients treated with GLP-1 receptor agonists compared with those not receiving these therapies

contact provider if persistent or severe For Fatigue : Ensure adequate calorie intake (track to avoid excessive deficit) Prioritize protein intake (preserve muscle, maintain energy) Ensure adequate sleep (7-9 hours) Rule out nutrient deficiencies with provider (B12, iron, vitamin D) Maintain regular light physical activity (paradoxically improves energy) Manage stress Important Safety Note: While these strategies help manage common side effects, always contact healthcare provider if symptoms are severe, persistent, or significantly impacting quality of life

Individuals who experience nausea from GLP-1 medications tend to be more common when first starting treatment or increasing the dosage

Krog-Mikkelsen I, Sloth B, Dimitrov D, Tetens I, Bjrck I, Flint A, et al

After 3 days of adaptation, d-allulose (1 g kg 1 ) or water (10 ml kg 1 ) was orally administered once daily at LP onset (7:30) for 10 days, and oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) were synchronously measured for 10 days